COVID-19 insights from transfusion medicine.
作者信息
Flegel Willy A
机构信息
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Huazhong University of Science and Technology, Wuhan, Hubei, China.
出版信息
Br J Haematol. 2020 Sep;190(5):715-717. doi: 10.1111/bjh.17005. Epub 2020 Jul 28.
Abstract
摘要
相似文献
1
COVID-19 insights from transfusion medicine.输血医学对2019冠状病毒病的见解
Br J Haematol. 2020 Sep;190(5):715-717. doi: 10.1111/bjh.17005. Epub 2020 Jul 28.
2
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与输血医学：来自意大利的思考
Blood Transfus. 2020 Mar;18(2):77-78. doi: 10.2450/2020.0071-20.
3
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.来自新冠病毒感染康复者的捐赠者血浆——优先事项问题
Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12.
4
Rolling with the changes.随变化而变。
Transfusion. 2020 May;60(5):885. doi: 10.1111/trf.15809. Epub 2020 Apr 22.
5
Anesthesiology and the Anesthesiologists at COVID-19.麻醉学与麻醉医生在2019冠状病毒病中的情况
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Jun-Jul;67(6):289-291. doi: 10.1016/j.redar.2020.05.005. Epub 2020 May 30.
6
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation.尽管在献血后出现症状的献血者血液中检测到RNA，但尚无证据表明SARS-CoV-2可通过输血传播。
Blood. 2020 Oct 15;136(16):1888-1891. doi: 10.1182/blood.2020008230.
7
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.ABO血型与新型冠状病毒肺炎风险之间的关联。
Br J Haematol. 2020 Jul;190(1):24-27. doi: 10.1111/bjh.16797. Epub 2020 May 26.
8
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
9
The association between COVID-19 and asthma: A systematic review and meta-analysis.2019冠状病毒病与哮喘之间的关联：一项系统评价和荟萃分析。
Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.
10
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?新冠病毒肺炎：医疗保健和输血医学领域会出现范式转变吗？
Transfus Clin Biol. 2020 Apr;27(2):59-60. doi: 10.1016/j.tracli.2020.03.005. Epub 2020 Mar 31.
引用本文的文献
1
Patient Blood Management and Its Role in Supporting Blood Supply.患者血液管理及其在支持血液供应中的作用。
J Blood Med. 2023 Nov 30;14:595-611. doi: 10.2147/JBM.S387322. eCollection 2023.
2
Predictors of Red Blood Cell Transfusion in Elderly COVID-19 Patients in Korea.韩国老年 COVID-19 患者红细胞输血的预测因素。
Ann Lab Med. 2022 Nov 1;42(6):659-667. doi: 10.3343/alm.2022.42.6.659.
3
Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic.COVID-19 大流行期间九个月内意大利住院患者的血液供应、输血需求和死亡率。
Blood Transfus. 2022 Jul;20(4):292-298. doi: 10.2450/2021.0173-21. Epub 2021 Nov 29.
4
Mortality and Transfusion Requirements in COVID-19 Hospitalized Italian Patients According to Severity of the Disease.根据疾病严重程度分析意大利新冠肺炎住院患者的死亡率及输血需求
J Clin Med. 2021 Jan 11;10(2):242. doi: 10.3390/jcm10020242.
5
COVID-19: risk of infection is high, independently of ABO blood group.新型冠状病毒肺炎：无论ABO血型如何，感染风险都很高。
Haematologica. 2020 Dec 1;105(12):2706-2708. doi: 10.3324/haematol.2020.266593.
6
Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea.韩国人群中新冠病毒肺炎患者的输血需求：韩国一项全国性研究
Br J Haematol. 2020 Sep;190(6):e323-e326. doi: 10.1111/bjh.17030. Epub 2020 Sep 9.
本文引用的文献
1
Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.COVID-19 感染患者重症监护中血液成分的使用：单中心经验。
Br J Haematol. 2020 Nov;191(3):382-385. doi: 10.1111/bjh.17007. Epub 2020 Oct 21.
2
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.恢复期血浆输注后重症或危重症 COVID-19 患者的临床症状和死亡率改善。
Blood. 2020 Aug 6;136(6):755-759. doi: 10.1182/blood.2020007079.
3
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.ABO 血型分布与 COVID-19 患者临床特征的关系。
Clin Chim Acta. 2020 Oct;509:220-223. doi: 10.1016/j.cca.2020.06.026. Epub 2020 Jun 17.
4
COVID-19 and ABO blood groups.新型冠状病毒肺炎与ABO血型
Transfusion. 2020 Aug;60(8):1883-1884. doi: 10.1111/trf.15946. Epub 2020 Aug 1.
5
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.全基因组关联研究严重新冠肺炎伴呼吸衰竭。
N Engl J Med. 2020 Oct 15;383(16):1522-1534. doi: 10.1056/NEJMoa2020283. Epub 2020 Jun 17.
6
Is SARS-CoV-2 transfusion transmitted?SARS-CoV-2 是否经输血传播？
Transfusion. 2020 Jun;60(6):1111-1114. doi: 10.1111/trf.15831.
7
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.恢复期血浆疗法对重症和危及生命的 COVID-19 患者临床改善时间的影响：一项随机临床试验。
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
8
Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19).新型冠状病毒（COVID-19）相关的冷凝集素自身免疫性溶血性贫血
Br J Haematol. 2020 Aug;190(4):e183-e184. doi: 10.1111/bjh.16892. Epub 2020 Jun 16.
9
Efficacy of therapeutic plasma exchange in severe COVID-19 patients.治疗性血浆置换在重症新型冠状病毒肺炎患者中的疗效
Br J Haematol. 2020 Aug;190(4):e181-e183. doi: 10.1111/bjh.16890. Epub 2020 Jun 12.
10
COVID-19 and ABO blood group: another viewpoint.新型冠状病毒肺炎与ABO血型：另一种观点。
Br J Haematol. 2020 Jul;190(2):e93-e94. doi: 10.1111/bjh.16884. Epub 2020 Jun 8.
Zotero 插件